CARR vs RANI · P/E 43, rev $21.75B vs rev $3.4M
Carrier Global Corp (CARR) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. RANI currently screens at market cap $41.5M.
Not investment advice. Open the CARR and RANI stock pages for the full models.
Not investment advice.